[HTML][HTML] Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study
J van Dalem, NCC Werkman, JP van den Bergh… - Diabetes Research and …, 2022 - Elsevier
Aims Sodium-glucose co-transporter-2 (SGLT-2) inhibitor-induced weight loss might play a
role in the debated elevated fracture risk with these agents. The aim of the current study was …
role in the debated elevated fracture risk with these agents. The aim of the current study was …
Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study
J van Dalem, NCC Werkman… - Diabetes research …, 2022 - pubmed.ncbi.nlm.nih.gov
Aims Sodium-glucose co-transporter-2 (SGLT-2) inhibitor-induced weight loss might play a
role in the debated elevated fracture risk with these agents. The aim of the current study was …
role in the debated elevated fracture risk with these agents. The aim of the current study was …
[HTML][HTML] Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study
J van Dalem, NCC Werkman… - Diabetes …, 2022 - diabetesresearchclinicalpractice …
Aims Sodium-glucose co-transporter-2 (SGLT-2) inhibitor-induced weight loss might play a
role in the debated elevated fracture risk with these agents. The aim of the current study was …
role in the debated elevated fracture risk with these agents. The aim of the current study was …
Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study
J van Dalem, NCC Werkman… - Diabetes …, 2022 - research-collection.ethz.ch
Aims: Sodium-glucose co-transporter-2 (SGLT-2) inhibitor-induced weight loss might play a
role in the debated elevated fracture risk with these agents. The aim of the current study was …
role in the debated elevated fracture risk with these agents. The aim of the current study was …
Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study
J van Dalem, NC Werkman, JP van den Bergh… - Diabetes Research and …, 2022 - vbn.aau.dk
AIMS: Sodium-glucose co-transporter-2 (SGLT-2) inhibitor-induced weight loss might play a
role in the debated elevated fracture risk with these agents. The aim of the current study was …
role in the debated elevated fracture risk with these agents. The aim of the current study was …
[PDF][PDF] USE OF SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS, CHANGES IN BODY MASS INDEX AND RISK OF FRACTURE: A POPULATION-BASED …
J van Dalem, NCC Werkman… - … therapy in type 2 …, 2022 - cris.maastrichtuniversity.nl
Background There is conflicting evidence regarding the effect of sodium-glucose co-
transporter-2 (SGLT-2) inhibitors on bone mineral density and fracture risk. Although weight …
transporter-2 (SGLT-2) inhibitors on bone mineral density and fracture risk. Although weight …
[PDF][PDF] USE OF SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS, CHANGES IN BODY MASS INDEX AND RISK OF FRACTURE: A POPULATION-BASED …
J van Dalem, NCC Werkman… - Tailored therapy in …, 2022 - apotheek.mumc.nl
Background There is conflicting evidence regarding the effect of sodium-glucose co-
transporter-2 (SGLT-2) inhibitors on bone mineral density and fracture risk. Although weight …
transporter-2 (SGLT-2) inhibitors on bone mineral density and fracture risk. Although weight …
[PDF][PDF] Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study
J van Dalem, NCC Werkman… - … and Clinical Practice, 2022 - researchgate.net
Aims: Sodium-glucose co-transporter-2 (SGLT-2) inhibitor-induced weight loss might play a
role in the debated elevated fracture risk with these agents. The aim of the current study was …
role in the debated elevated fracture risk with these agents. The aim of the current study was …
Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: a population-based cohort study
J van Dalem, NCC Werkman… - Diabetes …, 2022 - cris.maastrichtuniversity.nl
AIMS: Sodium-glucose co-transporter-2 (SGLT-2) inhibitor-induced weight loss might play a
role in the debated elevated fracture risk with these agents. The aim of the current study was …
role in the debated elevated fracture risk with these agents. The aim of the current study was …
[PDF][PDF] Use of sodium-glucose co-transporter 2 inhibitors, changes in body mass index and risk of fracture: A population-based cohort study
J van Dalem, NCC Werkman, JP van den Bergh… - vbn.aau.dk
Aims: Sodium-glucose co-transporter-2 (SGLT-2) inhibitor-induced weight loss might play a
role in the debated elevated fracture risk with these agents. The aim of the current study was …
role in the debated elevated fracture risk with these agents. The aim of the current study was …